2022
DOI: 10.1016/j.micpath.2022.105447
|View full text |Cite
|
Sign up to set email alerts
|

A novel strategy for developing a tetravalent vaccine (dvac) against dengue utilizing conserved regions from all DENV proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 36 publications
0
0
0
Order By: Relevance